Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
American Regent history
American Regent company history timeline
1967 A group of dedicated professionals launch our company under the name American Quinine, which provides quality, parenteral products to medical communities within the US and Canada.
1996 American Regent Laboratories introduces Dexferrum® (iron dextran injection, USP).
2009 Luitpold acquires PharmaForce, Inc., broadening its line of generic, multisource injectables.
2013 Injectafer® (ferric carboxymaltose injection)* is FDA Approved. *Injectafer® is a registered trademark of Vifor (International) Inc., Switzerland
Venofer® (iron sucrose injection, USP), now the #1 selling IV iron in the US,* is approved. *Source: IMS, NSP Audit Dollars & Units 3 year MAT ending January 2017
2017 American Regent celebrates its 50th Anniversary
June 2018 United States History and Government Examination Regular size version (615 KB) Large type version (1.08 MB)
2018 FDA-approval and launch of the first preservative free generic Hydroxyprogesterone Caproate Injection, USP
August 2019 United States History and Government Examination Regular size version (585 KB) Large type version (648 MB)
January 2020 United States History and Government Examination Regular size version (562 KB) Large type version (665 MB)
Shirley, NY – April 1, 2021: Paul Diolosa assumed the role of President and CEO of American Regent, Inc., a Daiichi Sankyo Group company, effective today.
Rate American Regent's efforts to communicate its history to employees.
American Regent jobs
Do you work at American Regent?
Does American Regent communicate its history to new hires?
American Regent competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Akorn | 1971 | $682.4M | 2,227 | - |
| Hemispherx Biopharma, Inc. | 1990 | $335,000 | 33 | - |
| Hi-Tech Pharmacal | 1982 | $232.4M | 200 | - |
| Noven | 1987 | $520.0M | 586 | 11 |
| Genesis Pharmaceutical | - | $1.5M | 50 | - |
| Pharmacia | 1901 | $130.0M | 350 | - |
| DUSA Pharmaceuticals | 1991 | $45.3M | 50 | - |
| VIVUS | 1991 | $73.2M | 57 | 3 |
| Adams Respiratory Therapeutics | 1997 | $440.0M | 750 | - |
| Alpharma | 1975 | $350.0M | 2,000 | - |
American Regent history FAQs
Zippia gives an in-depth look into the details of American Regent, including salaries, political affiliations, employee data, and more, in order to inform job seekers about American Regent. The employee data is based on information from people who have self-reported their past or current employments at American Regent. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by American Regent. The data presented on this page does not represent the view of American Regent and its employees or that of Zippia.
American Regent may also be known as or be related to American Regent, American Regent Inc, American Regent, Inc., Luitpold Pharmaceuticals and Luitpold Pharmaceuticals, Inc.